Molgramostim

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Molgramostim
DrugBank Accession Number
DB12525
Background

Molgramostim has been used in trials studying the treatment of Bronchiectasis, Cystic Fibrosis, Pulmonary Alveolar Proteinosis, Acute Respiratory Distress Syndrome, and Autoimmune Pulmonary Alveolar Proteinosis.

Type
Biotech
Groups
Investigational
Biologic Classification
Protein Based Therapies
Other protein based therapies
Protein Chemical Formula
Not Available
Protein Average Weight
Not Available
Sequences
Not Available
Synonyms
  • Molgramostim

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
CyclophosphamideThe risk or severity of pulmonary toxicity can be increased when Molgramostim is combined with Cyclophosphamide.
Darbepoetin alfaThe risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Molgramostim.
ErythropoietinThe risk or severity of Thrombosis can be increased when Erythropoietin is combined with Molgramostim.
Methoxy polyethylene glycol-epoetin betaThe risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Molgramostim.
PeginesatideThe risk or severity of Thrombosis can be increased when Peginesatide is combined with Molgramostim.
VinblastineThe risk or severity of peripheral neuropathy can be increased when Molgramostim is combined with Vinblastine.
VincristineThe risk or severity of peripheral neuropathy can be increased when Molgramostim is combined with Vincristine.
VindesineThe risk or severity of peripheral neuropathy can be increased when Molgramostim is combined with Vindesine.
VinflunineThe risk or severity of peripheral neuropathy can be increased when Molgramostim is combined with Vinflunine.
VinorelbineThe risk or severity of peripheral neuropathy can be increased when Molgramostim is combined with Vinorelbine.
Interactions
Identify potential medication risks
Easily compare up to 40 drugs with our drug interaction checker.
Get severity rating, description, and management advice.
Learn more
Food Interactions
Not Available

Categories

ATC Codes
L03AA03 — Molgramostim
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
B321AL142J
CAS number
99283-10-0

References

General References
Not Available
PubChem Substance
347911341
RxNav
70161
Wikipedia
Molgramostim

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3CompletedTreatmentAcute Myeloid Leukemia (AML)1
3CompletedTreatmentPulmonary Alveolar Proteinosis, Autoimmune1
3RecruitingTreatmentPulmonary Alveolar Proteinosis, Autoimmune1
2CompletedTreatmentMycobacterium Infections, Nontuberculous1
2RecruitingTreatmentCoronavirus Disease 2019 (COVID‑19) / COVID-19 Pneumonia / Severe Acute Respiratory Syndrome (SARS) Pneumonia1
2RecruitingTreatmentRespiratory Distress Syndrome, Acute (ARDS)1
2RecruitingTreatmentVenous Leg Ulcer (VLU)1
2TerminatedTreatmentCystic Fibrosis (CF) / Mycobacterium Infections, Nontuberculous1
2, 3CompletedTreatmentPulmonary Alveolar Proteinosis, Autoimmune1
2, 3Unknown StatusTreatmentCutaneous Melanoma1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on October 20, 2016 22:43 / Updated on February 21, 2021 18:53